Brainsway wins FDA nod for PTSD test

Brainsway wins an investigational device exemption from the FDA to start testing its deep transcranial magnetic stimulation device in patients with post-traumatic stress disorder.

Brainsway, Food & Drug Administration (FDA)

News Well, Clinical Trials, Neuromodulation/Neurostimulation, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uK1L0e